Nanoform Finland Plc Stock Fundamentals
| NANOFH Stock | EUR 1.19 0.04 3.48% |
Nanoform Finland Plc fundamentals help investors to digest information that contributes to Nanoform Finland's financial success or failures. It also enables traders to predict the movement of Nanoform Stock. The fundamental analysis module provides a way to measure Nanoform Finland's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanoform Finland stock.
Nanoform |
Nanoform Finland Plc Company Return On Equity Analysis
Nanoform Finland's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nanoform Finland Return On Equity | -0.24 |
Most of Nanoform Finland's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanoform Finland Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Nanoform Finland Plc has a Return On Equity of -0.2422. This is 98.99% lower than that of the Healthcare sector and 99.34% lower than that of the Biotechnology industry. The return on equity for all Finland stocks is 21.87% lower than that of the firm.
Nanoform Finland Plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanoform Finland's current stock value. Our valuation model uses many indicators to compare Nanoform Finland value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanoform Finland competition to find correlations between indicators driving Nanoform Finland's intrinsic value. More Info.Nanoform Finland Plc is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanoform Finland by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanoform Finland's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nanoform Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nanoform Finland's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nanoform Finland could also be used in its relative valuation, which is a method of valuing Nanoform Finland by comparing valuation metrics of similar companies.Nanoform Finland is currently under evaluation in return on equity category among its peers.
Nanoform Fundamentals
| Return On Equity | -0.24 | |||
| Return On Asset | -0.13 | |||
| Operating Margin | (6.75) % | |||
| Current Valuation | 194.87 M | |||
| Shares Outstanding | 78.39 M | |||
| Shares Owned By Insiders | 24.75 % | |||
| Shares Owned By Institutions | 50.69 % | |||
| Price To Book | 2.85 X | |||
| Price To Sales | 84.43 X | |||
| Revenue | 1.95 M | |||
| Gross Profit | 1.79 M | |||
| EBITDA | (17.19 M) | |||
| Net Income | (19.69 M) | |||
| Cash And Equivalents | 94.82 M | |||
| Cash Per Share | 1.31 X | |||
| Total Debt | 6.68 M | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 20.56 X | |||
| Book Value Per Share | 1.18 X | |||
| Cash Flow From Operations | (14.35 M) | |||
| Earnings Per Share | (0.30) X | |||
| Target Price | 8.8 | |||
| Number Of Employees | 143 | |||
| Beta | 0.76 | |||
| Market Capitalization | 203.04 M | |||
| Total Asset | 99.35 M | |||
| Z Score | 18.0 | |||
| Net Asset | 99.35 M |
About Nanoform Finland Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nanoform Finland Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanoform Finland using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanoform Finland Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Nanoform Finland Oy provides nanotechnology and drug particle engineering services for the pharmaceutical and biotechnology industries in Finland and internationally. The company was founded in 2015 and is headquartered in Helsinki, Finland. Nanoform Finland operates under Biotechnology classification in Finland and is traded on Helsinki Exchange. It employs 87 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nanoform Stock
Nanoform Finland financial ratios help investors to determine whether Nanoform Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanoform with respect to the benefits of owning Nanoform Finland security.